Hereditary Angioedema Therapeutics Market Size & Growth Forecast 2027–2036, By Segments (Treatment, End-use, Route of Administration), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Chapter 1. Methodology and Scope

• Methodology segmentation & scope
• Market Definitions
• Research Methodology
• Research Scope and Assumptions

Chapter 2. Executive Summary

• Market Outlook
• Segment Outlook
• Competitive Insights

Chapter 3. Hereditary Angioedema Therapeutics Industry Insights

• Market Introduction
• Industry Value Chain Analysis
• Market Dynamics
  • Market Drivers Analysis
  • Market Restraints Analysis
  • Industry Opportunities
• Regulatory Framework
• Analysis Tools
  • Porter’s Analysis
    • Bargaining Power of the Suppliers
    • Bargaining Power of the Buyers
    • Threats of Substitution
    • Threats From New Entrants
  • PESTEL Analysis
    • Political Landscape
    • Economic and Social Landscape
    • Technological Landscape
    • Environmental Landscape
    • Legal Landscape

Chapter 4. Hereditary Angioedema Therapeutics Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Treatment

• C1-esterase Inhibitor Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Bradykinin B2 Receptor Antagonist Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Kallikrein Inhibitor Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 5. Hereditary Angioedema Therapeutics Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by End-use

• Prophylaxis Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• On-demand Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 6. Hereditary Angioedema Therapeutics Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Route of Administration

• Intravenous Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Subcutaneous Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Oral Segment Estimates and Forecasts, 2022–2036 (USD Billion)

Chapter 7. Hereditary Angioedema Therapeutics Market Estimates 2022–2036 (USD Billion) & Trend Analysis, by Region & Countries

• Hereditary Angioedema Therapeutics Share, By Region
• North America
  • Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • U.S.
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Canada
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
• Europe
  • Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • UK
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Germany
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • France
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Italy
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Spain
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Russia
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
• Asia Pacific
  • Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • China
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • India
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Japan
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Australia
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • South Korea
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
• Latin America
  • Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Mexico
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Brazil
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Argentina
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
• Middle East & Africa
  • Market Estimates and Forecasts, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
  • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • Saudi Arabia
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • UAE
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)
  • South Africa
    • Market Estimates and Forecasts, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Treatment, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by End-use, 2022–2036 (USD Billion)
    • Market Estimates and Forecast by Route of Administration, 2022–2036 (USD Billion)

Chapter 8. Competitive Landscape

• Company Overview
• Company Market Share Analysis
• Company Heat Map Analysis
• Company SWOT Analysis
• Company Financial Performance
• Strategy Mapping
  • Expansion
  • Mergers & Acquisition
  • Partnerships & Collaborations
  • New Product Launches
  • Research and Development
• Company Profiles
  • Takeda Pharmaceutical Company Limited (Japan)
  • CSL Limited (Australia)
  • Sanofi S.A. (France)
  • BioCryst Pharmaceuticals Inc. (United States)
  • Ionis Pharmaceuticals Inc. (United States)
  • KalVista Pharmaceuticals Inc. (United States)
  • Pharming Group N.V. (Netherlands)
  • Pharvaris N.V. (Netherlands)
  • Arrowhead Pharmaceuticals Inc. (United States)
  • Adverum Biotechnologies Inc. (United States)

List of Tables

• Global Hereditary Angioedema Therapeutics Market, 2022–2036 (USD Billion)
• Global Hereditary Angioedema Therapeutics Market, by Region, 2022–2036 (USD Billion)
• Global Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Global Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Global Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• C1-esterase Inhibitor Segment by Region, 2022–2036 (USD Billion)
• Bradykinin B2 Receptor Antagonist Segment by Region, 2022–2036 (USD Billion)
• Kallikrein Inhibitor Segment by Region, 2022–2036 (USD Billion)
• Others Segment by Region, 2022–2036 (USD Billion)
• Prophylaxis Segment by Region, 2022–2036 (USD Billion)
• On-demand Segment by Region, 2022–2036 (USD Billion)
• Intravenous Segment by Region, 2022–2036 (USD Billion)
• Subcutaneous Segment by Region, 2022–2036 (USD Billion)
• Oral Segment by Region, 2022–2036 (USD Billion)
• North America Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• North America Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• North America Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• U.S. Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• U.S. Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• U.S. Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Canada Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Canada Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Canada Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Europe Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Europe Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Europe Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• UK Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• UK Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• UK Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Germany Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Germany Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Germany Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• France Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• France Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• France Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Italy Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Italy Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Italy Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Spain Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Spain Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Spain Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Russia Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Russia Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Russia Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Asia Pacific Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Asia Pacific Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Asia Pacific Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• China Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• China Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• China Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• India Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• India Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• India Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Japan Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Japan Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Japan Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Australia Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Australia Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Australia Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• South Korea Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• South Korea Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• South Korea Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Latin America Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Latin America Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Latin America Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Mexico Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Mexico Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Mexico Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Brazil Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Brazil Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Brazil Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Argentina Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Argentina Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Argentina Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Middle East & Africa Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Middle East & Africa Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Middle East & Africa Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• UAE Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• UAE Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• UAE Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• Saudi Arabia Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• Saudi Arabia Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• Saudi Arabia Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)
• South Africa Hereditary Angioedema Therapeutics Market, by Treatment, 2022–2036 (USD Billion)
• South Africa Hereditary Angioedema Therapeutics Market, by End-use, 2022–2036 (USD Billion)
• South Africa Hereditary Angioedema Therapeutics Market, by Route of Administration, 2022–2036 (USD Billion)

List of Figures

• Market Snapshot
• Segment Snapshot
• Competitive Landscape Snapshot
• Industry Value Chain Analysis
• Market Dynamics
• PORTER’s Analysis
• PESTEL Analysis
• Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion), by Treatment
• C1-esterase Inhibitor Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Bradykinin B2 Receptor Antagonist Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Kallikrein Inhibitor Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Others Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion), by End-use
• Prophylaxis Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• On-demand Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion), by Route of Administration
• Intravenous Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Subcutaneous Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Oral Segment Estimates and Forecasts, 2022–2036 (USD Billion)
• Global Hereditary Angioedema Therapeutics Market Share, by Region
• North America Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• U.S. Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Canada Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Europe Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• UK Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Germany Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• France Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Italy Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Spain Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Russia Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Asia Pacific Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• China Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• India Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Japan Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Australia Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• South Korea Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Latin America Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Mexico Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Brazil Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Argentina Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Middle East & Africa Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• UAE Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Saudi Arabia Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• South Africa Hereditary Angioedema Therapeutics Market Estimates and Forecasts, 2022–2036 (USD Billion)
• Key Company Categorization
• Company Market Positioning
• Key Company Market Share Analysis